tiagabine has been researched along with Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akula, KK; Dhir, A; Kulkarni, SK | 1 |
| Duan, W; Jiang, M; Li, Q; Liang, Y; Masuda, N; Peng, Q; Ross, CA; Wang, W; Wang, X; Zhao, M | 1 |
2 other study(ies) available for tiagabine and Huntington Disease
| Article | Year |
|---|---|
Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Topics: Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; GABA Agonists; Glutathione; Huntington Disease; Lipid Peroxidation; Male; Memory Disorders; Motor Activity; Nipecotic Acids; Nitro Compounds; Nitroprusside; Propionates; Rats; Rats, Wistar; RNA; Rotarod Performance Test; Tiagabine | 2008 |
Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease.
Topics: Animals; Arginine; Asparagine; Disease Models, Animal; Female; Glutamine; Huntington Disease; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Neurologic Mutants; Mice, Transgenic; Neuroprotective Agents; Nipecotic Acids; PC12 Cells; Rats; Tiagabine | 2008 |